prostate cancer | Research | 10 pages | source: Urologic oncology | Added Jul 06, 2020
Men with high-grade disease and low PSA may have more aggressive cancer
This study examined health outcomes based on PSA (prostate specific antigen) levels in men with high-grade disease. Authors reported more aggressive cancers with low PSA compared to medium PSA. Low PSA appeared to progress similarly to high PSA in men with high-grade disease.
prostate cancer | Research | 10 pages | source: The Lancet. Oncology | Added Jul 04, 2020
Do different radiation doses lead to different side effects in prostate cancer?
The authors aimed to determine how radiotherapy influenced patient quality of life after treatment.
prostate cancer | Research | Treatment | 10 pages | source: Neurourology and urodynamics | Added Jul 02, 2020
Improvement of urinary tract symptoms in patients who underwent robot-assisted prostate surgery
The main aim of this study was to assess urinary tract symptoms (LUTS) in prostate cancer patients following robotic-assisted laparoscopic prostatectomy (RALP). The authors concluded that the majority of patients with moderate to severe LUTS improved significantly following RALP.
prostate cancer | Research | Treatment | 10 pages | source: The New England Journal of Medicine | Added Jun 30, 2020
Slowing cancer progression before chemotherapy
This study examined the benefit of enzalutamide (Xtandi) in treating patients with advanced prostate cancer requiring chemotherapy.
Researchers concluded that enzalutamide treatment results in delayed disease progression and increased overall survival.
prostate cancer | Research | 8 pages | source: Cancer | Added Jun 28, 2020
Classifying stage 2c prostate tumors as intermediate or high-risk
The authors aimed to determine whether patients with T2c prostate tumors had an intermediate or high-risk disease.
prostate cancer | Research | 10 pages | source: BMC cancer | Added Jun 26, 2020
Evaluating the risk of secondary cancers after internal radiation therapy in patients with prostate cancer
This study looked at the long-term risk of secondary cancers following brachytherapy (BT; internal radiation therapy) for prostate cancer. It found that treating prostate cancer with BT had a low risk of secondary cancers.
prostate cancer | Medivizor | source: Medivizor | Added Jun 23, 2020
Positive Thinking and Cancer-Myth-Making
Called the "Emperor of All Maladies." there's little doubt that a cancer diagnosis throws life completely out of control. Unfortunately, this chaos creates vulnerabilities that can and have been exploited. It is tempting to believe the idea that if you control your thoughts and make them positive, you can controlprostate cancer | Research | Treatment | 9 pages | source: European Urology | Added Jun 19, 2020
Hormone therapy before radiation therapy: reduced survival in low-risk prostate cancer?
This study investigated the effects of hormone therapy given before brachytherapy (a form of radiation therapy) on the survival of prostate cancer patients with at least one risk factor for coronary artery disease compared to those with no risk factors.
prostate cancer | Medivizor | source: Medivizor | Added Jun 17, 2020
Oncology Basics 2016: The Immune System and Immunotherapy
Oncology Basics 2016 continues with a look at the immune system and immunotherapy. As described in a previous post, one of the regulators of cell division and proliferation is the immune system. Harnessing the power of the immune system to attack and destroy cancer cells is a promising area ofprostate cancer | Research | 10 pages | source: Scientific reports | Added Jun 15, 2020
Can vitamin D levels influence the chances of survival in patients with prostate cancer?
This study examined the levels of vitamin D in patients with prostate cancer (PC) to see if they were linked to patients’ chances of survival. The results showed that patients with higher levels of active vitamin D had a greater chance of survival.
